ClinicalTrials.gov lists 1 registered trial of Melanotan II: 1 recruiting or about to, 0 running, 0 completed. Recruiting sites are in China. The largest is Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo (60 people).
This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard NB-UVB phototherapy for repigmentation in adults with stable nonsegmental vitiligo.
Registered trials include ones that haven't published results yet. Trials are matched on the compound's name and code names (Melanotan II, melanotan-II, melanotan 2) in the listed interventions.